Sunday, July 13, 2025 | 07:53 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Chinese Covid-19 vaccine expected to begin mass output this year: Report

The vaccine, jointly developed by the Beijing Institute of Biological Products and China National Biotec Group Co., has completed phase II testing

testing, private laboratories, labs, vaccines, doctors, nurses, health, coronavirus
premium

President Xi Jinping has promised to share any successful vaccine globally, but Chinese companies still face challenges

Bloomberg
A front-running Covid-19 vaccine candidate being developed in China is expected to be available as soon as the end of this year, according to a report published in the official Wechat account of the State-owned Assets Supervision and Administration Commission.

The vaccine, jointly developed by the Beijing Institute of Biological Products and China National Biotec Group Co., has completed phase II testing and may be ready for the market at the end of this year or early next year, said the report.

The production line for the vaccine will be fully disinfected and closed in preparation for output to start Saturday, and